Induction and persistence of abnormal testicular germ cells following gestational exposure to Di-(n-Butyl) phthalate in p53-null mice

Journal of Andrology

Volumn 33, Issue 3, 2012, Pages 505-513

  Saffarini, Camelia M ^a   Heger, Nicholas E ^a   Yamasaki, Hideki ^a   Liu, Tao ^b   Hall, Susan J ^a   Boekelheide, Kim ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Fetal testis; Multinucleated germ cells (MNGs); Testicular germ cell cancer (TGCC); Testis

Indexed keywords

ALKALINE PHOSPHATASE; DI (N BUTYL) PHTHALATE; OCTAMER TRANSCRIPTION FACTOR 4; PHTHALIC ACID; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CARCINOGENICITY; CELL DENSITY; CELL MATURATION; CONTROLLED STUDY; FEEDING; GENOTYPE; GERM CELL; GERM CELL TUMOR; GESTATIONAL AGE; HETEROZYGOSITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MULTINUCLEATED GERM CELL; NEWBORN; NONHUMAN; PERINATAL DRUG EXPOSURE; PERINATAL PERIOD; PLACENTA; PRIORITY JOURNAL; SEMINIFEROUS TUBULE; SPERMATOGENESIS; TESTIS; WEIGHT GAIN;

ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; DIBUTYL PHTHALATE; FEMALE; GONADAL DYSGENESIS; GPI-LINKED PROTEINS; ISOENZYMES; MALE; MICE; MICE, MUTANT STRAINS; OCTAMER TRANSCRIPTION FACTOR-3; PLASTICIZERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SPERMATOZOA; TESTIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862527514     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.111.013706     Document Type: Article

References (57)

1. Ahlgren M, Wohlfahrt J, Olsen LW, Sorensen TI, Melbye M. Birth weight and risk of cancer. Cancer. 2007;110:412-419
2. Akre O, Ekbom A, Hsieh CC, Trichopoulos D, Adami HO. Testicular nonseminoma and seminoma in relation to perinatal characteristics J Natl Cancer Inst. 1996;88:883-889
3. Barlow NJ, Foster PM. Pathogenesis of male reproductive tract lesions from gestation through adulthood following in utero exposure to di(n-butyl) phthalate. Toxicol Pathol. 2003;31:397-410
4. Barlow NJ, Phillips SL, Wallace DG, Sar M, Gaido KW, Foster PM Quantitative changes in gene expression in fetal rat testes following exposure to di(n-butyl) phthalate. Toxicol Sci. 2003;73:431-441
5. Brown LM, Pottern LM, Hoover RN. Prenatal and perinatal risk factors for testicular cancer. Cancer Res. 1986;46:4812-4816
6. Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, Lopez-Beltran A, Montironi R, Looijenga LH. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol. 2007;211:1-9
7. Donehower LA. The p53-deficient mouse: a model for basic and applied cancer studies. Semin Cancer Biol. 1996;7:269-278
8. Embree-Ku M, Boekelheide K. FasL deficiency enhances the development of tumors in p53+/2 mice. Toxicol Pathol. 2002;30:705-713
9. Embree-Ku M, Venturini D, Boekelheide K. Fas is involved in the p53-dependent apoptotic response to ionizing radiation in mouse testis. Biol Reprod. 2002;66:1456-1461
10. Ferrara D, Hallmark N, Scott H, Brown R, McKinnell C, Mahood IK, Sharpe RM. Acute and long-term effects of in utero exposure of rats to di(n-butyl) phthalate on testicular germ cell development and proliferation. Endocrinology. 2006;147:5352-5362
11. Fisher JS, Macpherson S, Marchetti N, Sharpe RM. Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate. Hum Reprod. 2003;18:1383-1394
12. Foster PM. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters Int J Androl. 2006;29:140-147, discussion 181-185
13. Gaido KW, Hensley JB, Liu D, Wallace DG, Borghoff S, Johnson KJ, Hall SJ, Boekelheide K. Fetal mouse phthalate exposure shows that gonocyte multinucleation is not associated with decreased testicular testosterone. Toxicol Sci. 2007;97:491-503
14. Heudorf U, Mersch-Sundermann V, Angerer J. Phthalates: toxicology and exposure. Int J Hyg Environ Health. 2007;210:623-634
15. Hoei-Hansen CE. Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads, extragonadal tumours, and in semen of infertile men. Cancer Treat Rev. 2008;34:348- 367
16. Hoei-Hansen CE, Olesen IA, Jorgensen N, Carlsen E, Holm M, Almstrup K, Leffers H, Rajpert-De Meyts E. Current approaches for detection of carcinoma in situ testis. Int J Androl 2007;30:398-404, discussion 404-405
17. Jones TD, Ulbright TM, Eble JN, Cheng L. OCT4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis Clin Cancer Res. 2004;10:8544-8547
18. Kleymenova E, Swanson C, Boekelheide K, Gaido KW. Exposure in utero to di(n-butyl) phthalate alters the vimentin cytoskeleton of fetal rat Sertoli cells and disrupts Sertoli cell-gonocyte contact. Biol Reprod. 2005;73:482-490
19. Lacerda HM, Akre O, Merletti F, Richiardi L. Time trends in the incidence of testicular cancer in childhood and young adulthood Cancer Epidemiol Biomarkers Prev. 2009;18:2042-2045
20. Lehmann KP, Phillips S, Sar M, Foster PM, Gaido KW. Dosedependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di (n-butyl) phthalate Toxicol Sci. 2004;81:60-68
21. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244-2250
22. Lottrup G, Andersson AM, Leffers H, Mortensen GK, Toppari J, Skakkebaek NE, Main KM. Possible impact of phthalates on infant reproductive health. Int J Androl. 2006;29:172-180, discussion 181-185
23. Lozano G, Liu G. Mouse models dissect the role of p53 in cancer and development. Semin Cancer Biol. 1998;8:337-344
24. Lozano G, Zambetti GP. What have animal models taught us about the p53 pathway? J Pathol. 2005;205:206-220
25. Mahood IK, Hallmark N, McKinnell C, Walker M, Fisher JS, Sharpe RM. Abnormal Leydig cell aggregation in the fetal testis of rats exposed to di (n-butyl) phthalate and its possible role in testicular dysgenesis. Endocrinology. 2005;146:613-623
26. Mahood IK, Scott HM, Brown R, Hallmark N, Walker M, Sharpe RM. In utero exposure to di(n-butyl) phthalate and testicular dysgenesis: comparison of fetal and adult end points and their dose sensitivity. Environ Health Perspect. 2007;115(suppl 1):55-61
27. Main KM, Skakkebaek NE, Virtanen HE, Toppari J. Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab. 2010;24:279-289
28. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 2003;97:63-70
29. Meulmeester E, Jochemsen AG. p53: a guide to apoptosis. Curr Cancer Drug Targets. 2008;8:87-97
30. Michos A, Xue F, Michels KB. Birth weight and the risk of testicular cancer: a meta-analysis. Int J Cancer. 2007;121:1123-1131
31. Mori C, Nakamura N, Dix DJ, Fujioka M, Nakagawa S, Shiota K, Eddy EM. Morphological analysis of germ cell apoptosis during postnatal testis development in normal and Hsp 70-2 knockout mice. Dev Dyn. 1997;208:125-136
32. Mylchreest E, Sar M, Wallace DG, Foster PM. Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di(n-butyl) phthalate. Reprod Toxicol 2002;16:19-28
33. Neale RE, Carriere P, Murphy MF, Baade PD. Testicular cancer in twins: a meta-analysis. Br J Cancer. 2008;98:171-173
34. Okumura-Nakanishi S, Saito M, Niwa H, Ishikawa F. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J Biol Chem 2005;280:5307-5317
35. Pesce M, Wang X, Wolgemuth DJ, Scholer H. Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech Dev. 1998;71:89-98
36. Peters H. Migration of gonocytes into the mammalian gonad and their differentiation. Philos Trans R Soc Lond B Biol Sci. 1970;259:91-101
37. Rajpert-De Meyts E, Bartkova J, Samson M, Hoei-Hansen CE, Frydelund-Larsen L, Bartek J, Skakkebaek NE. The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 2003;111:267-278, discussion 278-279
38. Rajpert-De Meyts E, Hanstein R, Jorgensen N, Graem N, Vogt PH, Skakkebaek NE. Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod. 2004;19: 1338-1344
39. Rasmussen F, Gunnell D, Ekbom A, Hallqvist J, Tynelius P. Birth weight, adult height, and testicular cancer: cohort study of 337,249 Swedish young men. Cancer Causes Control. 2003;14:595-598
40. Richiardi L, Askling J, Granath F, Akre O. Body size at birth and adulthood and the risk for germ-cell testicular cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:669-673
41. Richiardi L, Bellocco R, Adami HO, Torrang A, Barlow L, Hakulinen T, Rahu M, Stengrevics A, Storm H, Tretli S, Kurtinaitis J, Tyczynski JE, Akre O. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev. 2004;13:2157-2166
42. Rodriguez I, Ody C, Araki K, Garcia I, Vassalli P. An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesis. EMBO J. 1997;16: 2262-2270
43. Rucker EB 3rd, Dierisseau P, Wagner KU, Garrett L, Wynshaw-Boris A, Flaws JA, Hennighausen L. Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis Mol Endocrinol. 2000;14:1038-1052
44. Sharpe RM, Skakkebaek NE. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril. 2008;89:e33-e38
45. Shultz VD, Phillips S, Sar M, Foster PM, Gaido KW. Altered gene profiles in fetal rat testes after in utero exposure to di(n-butyl) phthalate. Toxicol Sci. 2001;64:233-242
46. Sinha Hikim AP, Swerdloff RS. Hormonal and genetic control of germ cell apoptosis in the testis. Rev Reprod. 1999;4:38-47
47. Skakkebaek NE, Holm M, Hoei-Hansen C, Jorgensen N, Rajpert-De Meyts E. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS. 2003;111:1-9, discussion 9-11
48. Skakkebaek NE, Rajpert-De Meyts E, Jorgensen N, Main KM, Leffers H, Andersson AM, Juul A, Jensen TK, Toppari J Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations. Int J Androl. 2007;30:198-204, discussion 204-205
49. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001;16: 972-978
50. Sonne SB, Almstrup K, Dalgaard M, Juncker AS, Edsgard D, Ruban L, Harrison NJ, Schwager C, Abdollahi A, Huber PE, Brunak S, Gjerdrum LM, Moore HD, Andrews PW, Skakkebaek NE, Rajpert-De Meyts E, Leffers H. Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res. 2009;69: 5241-5250
51. Swan SH. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res 2008;108:177-184
52. Swerdlow AJ, De Stavola BL, Swanwick MA, Mangtani P, Maconochie NE. Risk factors for testicular cancer: a case-control study in twins. Br J Cancer. 1999;80:1098-1102
53. Tripathi R, Mishra DP, Shaha C. Male germ cell development: turning on the apoptotic pathways. J Reprod Immunol. 2009;83:31-35
54. Venkatachalam S, Tyner SD, Pickering CR, Boley S, Recio L, French JE, Donehower LA. Is p53 haploinsufficient for tumor suppression? Implications for the p53+/2 mouse model in carcinogenicity testing. Toxicol Pathol. 2001;29(suppl):147-154
55. Witorsch RJ, Thomas JA. Personal care products and endocrine disruption: a critical review of the literature. Crit Rev Toxicol 2010;40(suppl 3):1-30
56. Yin Y, Stahl BC, DeWolf WC, Morgentaler A. p53-mediated germ cell quality control in spermatogenesis. Dev Biol. 1998;204:165-171
57. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130